BeStock  
Stocks › Medical Devices › LIVN

LivaNova LIVN

US equityMarket cap rank #2056Medical DevicesBrain-Computer Interface
$90.73 −$1.34 (-1.46%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $90.73 0.00%
Open$91.50
Prev close$92.07
Day range$90.15 – $93.16
Volume536.7K
Market cap$5.00B
P/E (TTM)26.0
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership117.4%+3.31 pts vs. prior quarter
Institutions holding393+11 vs. prior quarter
Insider trades (recent)29 buys / 20 sellsNet buying
Short interest11.55% of floatDays to cover 12.4 · as of 30 Oct 2026
Short-sale volume share17.6%5-day average of daily volume

Short-sale volume as % of daily volume

5%15%26%37%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$3.97M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$3.4MSuper−$547.3KBig−$612.4KMid−$2.0MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 37.7% of shares outstanding.

Largest holders

  • BlackRock14.05%
  • PRIMECAP Management Company7.57%
  • FMR7.22%
  • Hood River Capital Management LLC4.66%
  • AQR Capital Management4.25%
  • Invesco Ltd.4.12%
  • Artisan Partners Limited Partnership4.04%
  • State Street Global Advisors3.93%

By investor type

  • Mutual Fund97.66%
  • Hedge Fund10.23%
  • Public Company4.86%
  • Government Pension Fund1.91%
  • Insurance Company1.61%
  • Private Company0.47%
  • Individual/Insider0.44%
  • Sovereign Wealth Fund0.31%

Reported short interest has risen from 8.57% to 11.55% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +829,580 7.2%
Invesco Ltd. Mutual Fund 2026/Q3 +535,880 4.1%
UBS Asset Management Mutual Fund 2026/Q3 +240,039 1.0%
BlackRock Mutual Fund 2026/Q3 +174,322 14.0%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +155,226 1.2%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +113,564 0.2%
Barclays PLC Public Company 2026/Q3 +93,722 0.5%
Principal Global Investors, LLC Mutual Fund 2026/Q3 +68,815 0.5%
Mutual of America Capital Management LLC Insurance Company 2026/Q3 +68,084 0.2%
Hood River Capital Management LLC Mutual Fund 2026/Q3 +1,928,937 4.7%
FMR Mutual Fund 2026/Q3 +480,197 5.7%
BlackRock Mutual Fund 2026/Q3 +426,434 13.7%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +361,857 0.9%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +257,877 3.2%
Invesco Ltd. Mutual Fund 2026/Q3 +251,253 3.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
11 Nov 2026 Alex Shvartsburg Chief Financial Officer Automatic Disposition -2,500 $90.91 42,147
14 Sep 2026 Anne Liddy Chief Legal Officer Other Derivative Acquisition +6,291 – 6,291
9 Sep 2026 Francesco Bianchi Independent Non-Executive Director Open Market Disposition -3,500 $78.01 4,434
3 Sep 2026 Brooke Story Independent Director Open Market Disposition -2,300 $81.42 7,488
1 Sep 2026 Franco Poletti Former President of Cardiopulmonary Business Unit Intent to Sell (Form 144) -10,755 $82.09 –
30 Aug 2026 Francesco Bianchi Independent Non-Executive Director Open Market Disposition -1,650 $79.72 7,934
10 Aug 2026 Ahmet Tezel Chief Innovation Officer Derivative Exercise and Sale -12,692 $77.86 6,090
14 Jun 2026 Todd Schermerhorn Independent Non-Executive Director Derivative Exercise and Sale -486 $79.70 12,619
14 Jun 2026 Todd Schermerhorn Independent Non-Executive Director Other Derivative Acquisition +2,383 – 2,383
14 Jun 2026 Todd Schermerhorn Independent Non-Executive Director Derivative Exercise and Retained +3,556 – 12,619
14 Jun 2026 Peter Wilver Independent Director Derivative Exercise and Sale -486 $79.70 10,294
14 Jun 2026 Peter Wilver Independent Director Other Derivative Acquisition +2,383 – 2,383
14 Jun 2026 Peter Wilver Independent Director Derivative Exercise and Retained +3,556 – 10,294
14 Jun 2026 William Kozy Chairman of Board Derivative Exercise and Sale -682 $79.70 37,566
14 Jun 2026 William Kozy Chairman of Board Other Derivative Acquisition +2,383 – 2,383
14 Jun 2026 William Kozy Chairman of Board Derivative Exercise and Retained +4,999 – 37,566
14 Jun 2026 Stacy Seng Independent Non-Executive Director Derivative Exercise and Sale -486 $79.70 15,307
14 Jun 2026 Stacy Seng Independent Non-Executive Director Other Derivative Acquisition +2,383 – 2,383
14 Jun 2026 Stacy Seng Independent Non-Executive Director Derivative Exercise and Retained +3,556 – 15,307
14 Jun 2026 Donald Zurbay Independent Director Derivative Exercise and Sale -308 $79.70 2,252

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 6,362,366 11.5% 12.4
15 Oct 2026 6,199,576 11.3% 10.6
30 Sep 2026 6,003,050 10.9% 8.0
15 Sep 2026 5,375,448 9.8% 9.7
31 Aug 2026 4,987,757 9.1% 9.0
14 Aug 2026 4,721,380 8.6% 5.4

Discussion

No comments yet — be the first to weigh in on LIVN.

Sign in to join the discussion.

Scroll to Top